/

Mediar Therapeutics

Develops antibody therapies to halt and reverse organ fibrosis.

BiotechnologyPharmaceuticals mediartx.com ↗

Company facts

Founded: 2018
Employees: 49
Headquarters: United States
Type: Private
Funding: Series B · $76M · 2026